Fig. 1.
Soluble ICAM-1 concentrations increase significantly (ANOVA, p = 0.0009) from healthy donors to patients without lymph node metastasis (UICC I/II) to patients with lymph node metastases and distant metastases in CRC
Soluble ICAM-1 concentrations increase significantly (ANOVA, p = 0.0009) from healthy donors to patients without lymph node metastasis (UICC I/II) to patients with lymph node metastases and distant metastases in CRC